Ghent University Academic Bibliography

Journal Article
A1
open access

Do health professionals know about overdiagnosis in screening, and how are they dealing with it? A mixed-methods systematic scoping review

Veerle Piessens (UGent) , Ann Van den Bruel, An Piessens, Ann Van Hecke (UGent) , John Brandt Brodersen, Emelien Lauwerier (UGent) , Florian Stul (UGent) , An De Sutter (UGent) and Stefan Heytens (UGent)

(2025) PLOS ONE. 20(2).

Add to list

Journal Article

Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors

Elena Catanzaro (UGent) , Manuel Beltran-Visiedo, Lorenzo Galluzzi and Dmitri Krysko (UGent)

(2025) CELLULAR & MOLECULAR IMMUNOLOGY. 22(1). p.24-39

Add to list

Journal Article
A2
open access

The development of 177Lu-DOTA-CC-PSMA following a unified “Click Chemistry” protocol of synthesizing metal nuclide-conjugated radiopharmaceuticals

Xiaobei Zheng, Shuai Xue, Zhongqi Zhao, Shuxin Jin, Shuhua He, Lina Jia, Zheng Li, Christian Vanhove (UGent) , Filip De Vos (UGent) , Zijun Kuang, et al.

(2024) EJNMMI RADIOPHARMACY AND CHEMISTRY. 9(1).

Add to list

Sexual satisfaction and its predictors in patients with advanced cancer and their family caregivers in six European countries : baseline data from the DIAdIC study

Orphé Matthys (UGent) , Sigrid Dierickx (UGent) , Vincent Van Goethem (UGent) , Luc Deliens (UGent) , Lore Lapeire (UGent) , Aglaja De Pauw (UGent) , Peter Hudson, Christof Vulsteke, Karen Geboes (UGent) , Stefanie De Waele, et al.

(2024) PSYCHO-ONCOLOGY. 33(6).

Add to list

Journal Article
A1
open access

Potential application of [18F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma

Bliede Van den Broeck (UGent) , Jens Debacker (UGent) , Wouter Bauters (UGent) , David Creytens (UGent) , Liesbeth Ferdinande (UGent) , Wouter Huvenne (UGent) , Bruno Lapauw (UGent) , Vanessa Schelfhout (UGent) , Nick Van Laeken (UGent) and Charlotte Verroken (UGent)

(2024) EJNMMI RESEARCH. 14(1).

Add to list

Journal Article

Potential application of [<SUP>18</SUP>F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma

Bliede Van den Broeck, Jens M. Debacker, Wouter Bauters, David Creytens (UGent) , Liesbeth Ferdinande (UGent) , Wouter Huvenne (UGent) , Bruno Lapauw (UGent) , Vanessa Schelfhout (UGent) , Nick Van Laeken and Charlotte Verroken (UGent)

(2024) EJNMMI RESEARCH. 14(1).

Add to list

Journal Article
A1
open access

Characterization of non-specific uptake and retention mechanisms of [177Lu]Lu-PSMA-617 in the salivary glands

Nathalie Heynickx (UGent) , Charlotte Segers, Amelie Coolkens, Sarah Baatout (UGent) and Koen Vermeulen

(2023) PHARMACEUTICALS. 16(5).

Add to list

Journal Article
A1
open access

The epithelial-mesenchymal plasticity landscape: principles of design and mechanisms of regulation

Jef Haerinck (UGent) , Steven Goossens (UGent) and Geert Berx (UGent)

(2023) NATURE REVIEWS GENETICS. 24(9). p.590-609

Add to list

Miscellaneous

What really matters for cancer care : health systems strengthening or technological innovation?

A. Aggarwal, Yolande Lievens (UGent) , R. Sullivan and E. Nolte

(2022) CLINICAL ONCOLOGY. 34(7). p.430-435

Add to list

Journal Article
A1
open access

Neonatal Nav1.5 : pharmacological distinctiveness of a cancer‐related voltage‐gated sodium channel splice variant

Scott P. Fraser, Rustem Onkal, Margaux Theys (UGent) , Frank Bosmans (UGent) and Mustafa B. A. Djamgoz

(2022) BRITISH JOURNAL OF PHARMACOLOGY. 179(3). p.473-486

Academic Bibliography

Do health professionals know about overdiagnosis in screening, and how are they dealing with it? A mixed-methods systematic scoping review

Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors

The development of 177Lu-DOTA-CC-PSMA following a unified “Click Chemistry” protocol of synthesizing metal nuclide-conjugated radiopharmaceuticals

Sexual satisfaction and its predictors in patients with advanced cancer and their family caregivers in six European countries : baseline data from the DIAdIC study

Potential application of [18F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma

Potential application of [<SUP>18</SUP>F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma

Characterization of non-specific uptake and retention mechanisms of [177Lu]Lu-PSMA-617 in the salivary glands

The epithelial-mesenchymal plasticity landscape: principles of design and mechanisms of regulation

What really matters for cancer care : health systems strengthening or technological innovation?

Neonatal Nav1.5 : pharmacological distinctiveness of a cancer‐related voltage‐gated sodium channel splice variant

Contents

Support

Contact